Neumora Corp (NMRA): Rentabilitas operasi

Tandha merek Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics brings together leading neurobiologists and data scientists, investing in large-scale R&D. The EBIT margin reflects efficiency dynamics, with the metric currently at 0.00. The company is currently conducting clinical trials independently while forming technological alliances with scientific institutes. Financial success is based on the development of precision medicines for the treatment of schizophrenia and depression, which will later be procured by government systems.

NMRA: Margin operasi Neumora Therapeutics, Inc. 21.02.2024 - 20.11.2026

Rincian metrik lan analitis perusahaan Neumora Therapeutics, Inc. (NMRA)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:Neumora Therapeutics, Inc.
Produk dadi neumoratx.com

Fundamental analysis of this asset requires risk minimization through an assessment of operational process efficiency. For Neumora Therapeutics (NMRA), which develops patent-protected drugs for brain pathologies, the ability to generate internal cash flow is critical. Operating profit margin demonstrates the share of profit from core activities before accounting for financial expenses and taxes. This indicator measures the real efficiency of the business model without the influence of debt load, and its trend determines capital stability over the long term.

Pesaing langsung

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|Rentabilitas dodolan operasi prothena.com|Alector Therapeutics (ALEC) - Rentabilitas operasi|Annexon Biosciences Inc. - Tingkat bathi operasi|OMER (Omeros Corp) - Margin operasi|Margin operasi neurogene.com|Margin operasi ACIU|VYGR - Rentabilitas dodolan operasi|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi